• 2k views

Role of GLP 1 RA in Weight loss

GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.

About the Speaker

Dr. Leena Mahana Kapoor Profile Image

Dr. Leena Mahana Kapoor

Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai

Dr. Leena Mahana Kapoor, Specialist Internal Medicine and Diabetologist, Aster DM Healthcare, Dubai

Upcoming Case Discussions

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Leena Mahana Kapoor's Talks on Assimilate

webinar
Dr. Leena Mahana Kapoor
  • 07th-Mar -2025, TIME : 6:00PM TO 7:00 PM
  • 0

GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.

webinar
Dr. Leena Mahana Kapoor
  • 07th-Mar -2025, TIME : 6:00PM TO 7:00 PM
  • 0

GLP-1 receptor agonists (GLP-1 RAs) play a significant role in weight loss by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying, which helps reduce appetite and food intake. These medications, originally developed for managing type 2 diabetes, have been shown to promote substantial weight loss in overweight and obese individuals, even in the absence of diabetes. GLP-1 RAs, such as liraglutide and semaglutide, have been approved for weight management and are often used alongside lifestyle interventions. Their effectiveness in weight loss, combined with improved metabolic control, makes them a promising treatment option for individuals struggling with obesity.